Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders

BACKGROUND: Clinical trials evaluating anti-CD20-mediated B-cell depletion in multiple sclerosis (MS) and neuromyelitis optica (NMO) generated encouraging results. Our recent studies in the MS model experimental autoimmune encephalomyelitis (EAE) attributed clinical benefit to extinction of activate...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lehmann-Horn, Klaus, Schleich, Eva, Hertzenberg, Deetje, Hapfelmeier, Alexander, Kümpfel, Tania, von Bubnoff, Nikolas, Hohlfeld, Reinhard, Berthele, Achim, Hemmer, Bernhard, Weber, Martin S
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2011
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3214191/
https://ncbi.nlm.nih.gov/pubmed/22027448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-2094-8-146
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia